MedGenome is a genomics and clinical data-driven diagnostics and drug discovery research company founded in 2013.

Basic Information

MedGenome is a genomics and clinical data-driven diagnostics and drug discovery research company founded in 2013. MedGenome deals with genetic diagnostics in India and is one of the highest throughput NGS sequencing labs in South Asia. They possess state-of-the-art Next-generation Sequencing (NGS) facility, which houses genome sequencing platforms such as Illumina’s NovaSeq, HiSeq X, HiSeq 4000 and 2500, MiSeq, etc. Their sequencing facility is supported by an IHC pathology lab and they utilize modern molecular techniques such as FISH, PCR, Sanger Sequencing, and Microarray to offer comprehensive diagnostic solutions to researchers, doctors, and hospitals. They currently offer more than 475 genetic tests across several disease categories such as paediatrics, neurology, oncology, hematology, endocrinology and nephrology, ophthalmology. See more

Legal Name

:

MedGenome Labs Ltd.

Headquarters

:

Bangalore, Karnataka, India

Business Model

:

B2C, 

B2B 

Founding Date

:

2013

No. of Employees

:

251 to 500

Core Team

:
1.

Mahesh Pratapneni

Co-Founder

2.

Sam Santhosh

Co-Founder & CEO

Revenue Streams

Funding

Total Funding

$100.0M

Investors

:

1.

LeapFrog Investments

2.

Sofina

3.

Sequoia Capital

See More

Detail Round Breakdown

Round 1
Round 2
Round 3
Round 4

$4M

Series Name

:

SERIES-A

Date

:

1st Jul 2013